[Insufficient understanding of second @entity5 after childhood XXXX in Switzerland].

@entity1 @entity981 @entity0 @entity5 @entity3969 @entity3052 @entity1653 @entity421 @entity1893 @entity978 @entity995
@entity5 after childhood @entity5 is a well-known complication. However, frequency differs considerably according to the types of primary @entity5 and the specifics of therapy. Ten @entity1 with a second @entity5 after being cured of the @entity5 are described. There were 2 @entity1 with @entity981 , one with @entity1893 , and one with @entity0 after @entity978 . Two @entity1 with heritable @entity995 developed @entity421 in the irradiation field after a latent period of 7 and 14 years respectively. There was another @entity421 in a @entity3969 survivor. One @entity1 with @entity981 developed a secondary AML 10 years after achieving initial remission, and a @entity1653 was diagnosed in another @entity1 with cured @entity981 . One @entity1 died of peritoneal sarcomatosis of unknown origin 20 years after the diagnosis of @entity3052 . All @entity1 received radiotherapy for the primary @entity5 . @entity5 in other @entity1 were probably missed because they occurred in adulthood when the @entity1 were transferred to other medical centres. It is impossible to trace these @entity1 because central registration of @entity1 with @entity5 is lacking. It is therefore important to establish a central @entity5 registry for the whole of Switzerland. @entity5 after @entity5 is not a rare event and requires long-term follow-up of @entity1 with @entity5 .
